ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

White House Picks Harold Varmus For NCI

May 21, 2010

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

As Shutdown Nears, House Republicans Press For Deeper Cuts and Repeal of Obamacare

September 13, 2013

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991